Literature DB >> 21980073

CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

Yunguang Tong1, Jin Zhou, Jun Mizutani, Hidenori Fukuoka, Song-Guang Ren, Arthur Gutierrez-Hartmann, H Phillip Koeffler, Shlomo Melmed.   

Abstract

Hyperprolactinemia, usually caused by a pituitary lactotroph tumor, leads to galactorrhea and infertility. Increased prolactin (PRL) levels may be due to enhanced PRL expression or proliferation of PRL-secreting cells. We hypothesize that PRL expression and PRL-secreting cell proliferation are linked. Using microarray-based gene expression profiling, we identified CCAAT-enhancer-binding protein δ (CEBPD) transcription factor as a critical gene that regulates both PRL expression and lactotroph cell proliferation. CEBPD expression levels are decreased approximately 7-fold in experimental rat prolactinoma cells. Forced expression of this transcription factor in PRL-secreting cells (GH3 and MMQ) inhibited PRL expression and cellular proliferation, and CEBPD knockdown by small interfering RNA leads to increased PRL expression in both cell lines. To determine mechanisms underlying this observation, we determined binding of CEBPD to the PRL promoter and also showed marked suppression (96%) of PRL promoter activity. CEBPD and Pit1 interact and attenuate each other's binding to the PRL promoter. CEBPD also suppresses expression of proliferation-related genes, including c-Myc, survivin, as well as cyclins B1, B2, and D1. These results show that PRL expression and cell proliferation are controlled in part by CEBPD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21980073      PMCID: PMC3198962          DOI: 10.1210/me.2011-1075

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  42 in total

1.  Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification.

Authors:  K M Scully; E M Jacobson; K Jepsen; V Lunyak; H Viadiu; C Carrière; D W Rose; F Hooshmand; A K Aggarwal; M G Rosenfeld
Journal:  Science       Date:  2000-11-10       Impact factor: 47.728

2.  Epidermal growth factor induces a sexually dimorphic proliferative response of lactotroph cells through protein kinase C-ERK1/2-Pit-1 in vitro.

Authors:  Ana Lucía De Paul; Silvina Gutiérrez; María E Sabatino; Jorge H Mukdsi; Claudia M Palmeri; Marta Soaje; Juan P Petiti; Alicia I Torres
Journal:  Exp Physiol       Date:  2011-02       Impact factor: 2.969

Review 3.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 4.  Gene therapy in the neuroendocrine system.

Authors:  C B Hereñú; G R Morel; M J Bellini; P C Reggiani; Y E Sosa; O A Brown; R G Goya
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

5.  CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.

Authors:  Takayuki Ikezoe; Sigal Gery; Dong Yin; James O'Kelly; Lise Binderup; Nathan Lemp; Hirokuni Taguchi; H Phillip Koeffler
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

6.  Pit-1/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line.

Authors:  C Gil-Puig; M Blanco; T García-Caballero; C Segura; R Pérez-Fernández
Journal:  J Endocrinol       Date:  2002-04       Impact factor: 4.286

7.  A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors.

Authors:  M Imaizumi; T Kondo; T Taguchi; T Hattori; O Abe; M Kitano; A Wakui
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Transactivation of the 'promoterless' luciferase-encoding vectors pXP1 and pXP2 by C/EBP alpha.

Authors:  Y C Li; S Hayes; A P Young
Journal:  Gene       Date:  1994-01-28       Impact factor: 3.688

9.  Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.

Authors:  Anna Gruszka; Song-Guang Ren; Jesse Dong; Michael D Culler; Shlomo Melmed
Journal:  Endocrinology       Date:  2007-07-26       Impact factor: 4.736

10.  E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression.

Authors:  Monica Fedele; Giovanna Maria Pierantoni; Rosa Visone; Alfredo Fusco
Journal:  Cell Div       Date:  2006-08-17       Impact factor: 5.130

View more
  8 in total

1.  CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.

Authors:  Tony Valente; Guido Dentesano; Mario Ezquerra; Ruben Fernandez-Santiago; Jonatan Martinez-Martin; Edurne Gallastegui; Carla Domuro; Yaroslau Compta; Maria J Martí; Oriol Bachs; Leonardo Márquez-Kisinousky; Marco Straccia; Carme Solà; Josep Saura
Journal:  Cell Death Differ       Date:  2019-06-17       Impact factor: 15.828

2.  Genomic analyses identify agents regulating somatotroph and lactotroph functions.

Authors:  Jun Fan; Cui Zhang; Qi Chen; Jin Zhou; Jean-Louis Franc; Qing Chen; Yunguang Tong
Journal:  Funct Integr Genomics       Date:  2016-10-05       Impact factor: 3.410

3.  Genomic characterization of human and rat prolactinomas.

Authors:  Yunguang Tong; Yun Zheng; Jin Zhou; Nelson M Oyesiku; H Phillip Koeffler; Shlomo Melmed
Journal:  Endocrinology       Date:  2012-05-25       Impact factor: 4.736

Review 4.  The many faces of C/EBPδ and their relevance for inflammation and cancer.

Authors:  Kuppusamy Balamurugan; Esta Sterneck
Journal:  Int J Biol Sci       Date:  2013-09-20       Impact factor: 6.580

5.  Natural and molecular history of prolactinoma: insights from a Prlr-/- mouse model.

Authors:  Valérie Bernard; Chiara Villa; Aurélie Auguste; Sophie Lamothe; Anne Guillou; Agnès Martin; Sandrine Caburet; Jacques Young; Reiner A Veitia; Nadine Binart
Journal:  Oncotarget       Date:  2017-12-27

6.  Postnatal developmental trajectory of sex-biased gene expression in the mouse pituitary gland.

Authors:  Huayun Hou; Cadia Chan; Kyoko E Yuki; Dustin Sokolowski; Anna Roy; Rihao Qu; Liis Uusküla-Reimand; Mariela Faykoo-Martinez; Matt Hudson; Christina Corre; Anna Goldenberg; Zhaolei Zhang; Mark R Palmert; Michael D Wilson
Journal:  Biol Sex Differ       Date:  2022-10-11       Impact factor: 8.811

7.  Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation.

Authors:  Qiaoqiao Li; Yingyu Lai; Xiaoyan Gao; Xin Li; Chun-Yu Deng; Huiming Guo; Junfei Zhao; Hui Yang; Yuwen Xu; Shulin Wu; Yumei Xue; Fang Rao
Journal:  PeerJ       Date:  2021-06-02       Impact factor: 2.984

8.  Gene signatures of drug resistance predict patient survival in colorectal cancer.

Authors:  Y Zheng; J Zhou; Y Tong
Journal:  Pharmacogenomics J       Date:  2014-09-02       Impact factor: 3.550

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.